|
|
| Line 36: |
Line 36: |
|
| |
|
| ===10:00 AM=== | | ===10:00 AM=== |
| ''10:00 AM – 10:30 AM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Masahiro Natsuaki
| |
| *'''Topic:''' One-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
| |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 8:36 AM
| |
|
| |
|
| ===10:30 AM=== | | ===10:30 AM=== |
| ''10:30 AM – 11:00 AM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Margaret Redfield
| |
| *'''Topic:''' Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) Trial
| |
| *'''Embargo lift:''' Monday, March 11, 2013 at 11:30 AM
| |
|
| |
|
| ===4:00 PM=== | | ===4:00 PM=== |
| ''4:00 PM – 4:30 PM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Jane Margaret Armitage
| |
| *'''Topic:''' HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673 Patients At High Risk Of Occlusive Vascular Events
| |
| *'''Embargo lift:''' Saturday, March 9, 2013 at 9:40 AM
| |
|
| |
|
| ===4:30 PM=== | | ===4:30 PM=== |
| ''4:30 PM – 5:00 PM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Anna Toso
| |
| *'''Topic:''' Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome
| |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 8:00 AM
| |
|
| |
|
| ===5:00 PM=== | | ===5:00 PM=== |
| ''5:00 PM – 5:15 PM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Jean Claude Tardif
| |
| *'''Topic:''' Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
| |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 11:21 AM
| |
|
| |
|
| == Sunday, September 1, 2013== | | == Sunday, September 1, 2013== |
|
| |
|
| ===10:00 AM=== | | ===10:00 AM=== |
| ''10:00 AM – 10:30 AM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Gregory Piazza
| |
| *'''Topic:''' APEX Trial: Research in Acute Medically Ill Populations
| |
|
| |
|
| ===1:30 PM=== | | ===1:30 PM=== |
| ''1:30 PM – 2:00 PM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Renato Lopes
| |
| *'''Topic:''' ACC Wrap-Up in Portuguese
| |
|
| |
|
| ===2:00 PM=== | | ===2:00 PM=== |
| ''2:00 PM – 2:30 PM'' | | ''2:00 PM – 2:30 PM'' |
| *'''Interviewee:''' Dr. Mikhail Kosiborod | | *'''Interviewee:''' |
| *'''Topic:''' Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Randomized Clinical Trial | | *'''Topic:''' |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 11:57 AM | | *'''Embargo lift:''' |
|
| |
|
| ===2:30 PM=== | | ===2:30 PM=== |
| ''2:30 PM – 3:00 PM''
| | <font color=red>OPEN TIME SLOT</font> |
| *'''Interviewee:''' Dr. Freek W.A. Verheugt and Dr. J.H. Cornel
| |
| *'''Topic:''' ACC Wrap-Up from a Dutch perspective
| |
|
| |
|
| ===3:00 PM=== | | ===3:00 PM=== |
| ''3:00 PM – 3:30 PM''
| |
| *'''Interviewee:''' Dr. David R. Holmes
| |
| *'''Topic:''' Final Results of Randomized Trial of Left Atrial Appendage Closure Versus Warfarin for Stroke/Thromboembolic Prevention in Patients with Non-Valvular Atrial Fibrillation (PREVAIL)
| |
| *'''Embargo lift:''' Saturday, March 9, 2013 at 9:00 AM
| |
|
| |
| ===3:30 PM===
| |
| ''3:30 PM – 4:00 PM''
| |
| *'''Interviewee:''' Dr. Gilles Montalescot
| |
| *'''Topic:''' Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER Trial and ACC Wrap-Up in French
| |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 11:03 AM
| |
|
| |
| ===4:00 PM===
| |
| ''4:00 PM – 4:30 PM''
| |
| *'''Interviewee:''' Dr. Basil Lewis
| |
| *'''Topic:''' ACC Wrap-Up in Hebrew
| |
|
| |
| ===4:15 PM===
| |
| ''4:15 PM – 4:30 PM''
| |
| *'''Interviewee:''' Dr. Harvey White
| |
| *'''Topic:''' ACC Wrap-Up from a Pacific Rim Perspective
| |
|
| |
| ===4:30 PM===
| |
| ''4:30 PM – 4:45 PM''
| |
| *'''Interviewee:''' Dr. Andre Lamy
| |
| *'''Topic:''' CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study Results at 1 Year
| |
| *'''Embargo lift:''' Monday, March 11, 2013 at 8:54 AM
| |
|
| |
| ===4:45 PM===
| |
| ''4:45 PM – 5:00 PM''
| |
| *'''Interviewee:''' Dr. Alice K. Jacobs
| |
| *'''Topic:''' A Randomized Trial to Compare Percutaneous Coronary Intervention between Massachusetts Hospitals with Cardiac Surgery On-Site and Community Hospitals without Cardiac Surgery On-Site
| |
| *'''Embargo lift:''' Monday, March 11, 2013 at 8:18 AM
| |
|
| |
|
| == Monday, September 2, 2013== | | == Monday, September 2, 2013== |
|
| |
| ===9:00 AM===
| |
| <font color=red>OPEN TIME SLOT</font>
| |
|
| |
| ===9:30 AM===
| |
| ''9:30 AM – 10:00 AM''
| |
| *'''Interviewee:''' Dr. Sergio Leonardi and Dr. Marco Valgimigli
| |
| *'''Topic:''' ACC Wrap-Up in Italian
| |
|
| |
| ===10:00 AM===
| |
| ''10:00 AM – 10:30 AM''
| |
| *'''Interviewee:''' Dr. Stefan James
| |
| *'''Topic:''' ACC Wrap-Up from a Scandinavian Perspective
| |
|
| |
| ===10:30 AM===
| |
| <font color=red>OPEN TIME SLOT</font>
| |
|
| |
| ===11:00 AM===
| |
| ''11:00 AM – 11:30 AM''
| |
| *'''Interviewee:''' Dr. Robert Harrington
| |
| *'''Topic:''' APEX Social Media: Social Media and the Utility in Clinical Trials
| |
|
| |
| ===11:30 AM===
| |
| ''11:30 AM – 12:00 PM''
| |
| *'''Interviewee:''' Dr. Sigmund Silber
| |
| *'''Topic:''' ACC Wrap-Up in German
| |
|
| |
| ===1:30 PM===
| |
| ''1:30 PM – 2:00 PM''
| |
| *'''Interviewee:''' Dr. Junjie Zhang
| |
| *'''Topic:''' Comparison of DK Crush Versus Culotte Stenting for Unprotected Distal Left Main Bifurcation Lesions: Results From a Multicenter, Randomized, Prospective DKCRUSH-III Study
| |
| *'''Embargo lift:''' Sunday, March 10, 2013 at 8:54 AM
| |
|
| |
| ===2:00 PM===
| |
| ''2:00 PM – 2:30 PM''
| |
| *'''Interviewee:''' Dr. Hisao Ogawa
| |
| *'''Topic:''' Topic: ACC Wrap-Up in Japanese
| |
|
| |
| ===2:30 PM===
| |
| ''2:30 PM – 3:00 PM''
| |
| *'''Interviewee:''' Dr. Ali Ahmed
| |
| *'''Topic:''' Digoxin Reduces 30-Day All-Cause Hospital Admission in Ambulatory Older Patients with Chronic Heart Failure and Reduced Ejection Fraction
| |
| *'''Embargo lift:''' Monday, March 11, 2013 at 11:00 AM
| |
|
| |
| ===3:00 PM===
| |
| <font color=red>OPEN TIME SLOT</font>
| |
|
| |
|
| |
|
| == Tuesday, September 3, 2013== | | == Tuesday, September 3, 2013== |
|
| |
| ===9:00 AM===
| |
| <font color=red>OPEN TIME SLOT</font>
| |
|
| |
| ===9:30 AM===
| |
| ''9:30 AM – 10:00 AM''
| |
| *'''Interviewee:''' Dr. Sergio Leonardi and Dr. Marco Valgimigli
| |
| *'''Topic:''' ACC Wrap-Up in Italian
| |
|
| |
| ===10:00 AM===
| |
| ''10:00 AM – 10:30 AM''
| |
| *'''Interviewee:''' Dr. Stefan James
| |
| *'''Topic:''' ACC Wrap-Up from a Scandinavian Perspective
| |
|
| |
| ===10:30 AM===
| |
| <font color=red>OPEN TIME SLOT</font>
| |